Quick answer : Benzodiazepines and ketamine can sometimes be used in the same patient, but the combination requires individualized medical review. Research has raised the possibility that benzodiazepines, particularly at higher doses, may reduce or delay ketamine’s antidepressant effects in some patients. Benzodiazepines should never be abruptly stopped simply to receive ketamine because withdrawal can be dangerous.
Many people considering ketamine for treatment-resistant depression or severe anxiety already take medications such as alprazolam, lorazepam, clonazepam, or diazepam. Doctors commonly prescribe these medications for anxiety, panic attacks, insomnia, and other conditions.
Patients naturally want to know whether they can continue taking a benzodiazepine during ketamine treatment. The answer depends on several factors, including the medication, dose, frequency of use, length of treatment, reason for use, and risk of withdrawal.
Taking a benzodiazepine does not automatically prevent someone from receiving ketamine. However, the treating clinician should consider the medication as part of the overall treatment plan.
Researchers continue to study this question. Some clinical studies have found that benzodiazepine use, particularly at higher doses, may correlate with a weaker or delayed antidepressant response to ketamine.
More recent reviews have also examined medications taken alongside ketamine or esketamine as potential factors in treatment response.
However, an association does not prove that benzodiazepines prevent ketamine from working. Patients who take benzodiazepines may also differ from other patients in important ways. They may have more severe anxiety, greater illness severity, sleep problems, or other clinical factors that influence treatment response.
For that reason, clinicians should interpret the available evidence carefully rather than apply one universal rule to every patient.
Ketamine and benzodiazepines affect different neurotransmitter systems. Ketamine primarily influences glutamate signaling, while benzodiazepines enhance signaling through GABA-A receptors.
Researchers have questioned whether these different effects could influence some of the changes associated with ketamine treatment. The balance between inhibitory and excitatory signaling plays an important role in neural activity and plasticity.
Research in this area continues to evolve. At this time, no precise benzodiazepine dose or timing rule applies to every patient.
Patients should make this decision with their treating clinician rather than changing their medication schedule on their own.
Someone who uses a benzodiazepine occasionally has different considerations from someone who takes a substantial daily dose for several years.
The clinician may consider the medication’s half-life, dose, frequency, reason for use, and the patient’s previous experience when delaying or missing a dose.
The safest approach is to tell the ketamine clinician exactly what you take. This includes medications prescribed by another physician.
Regular benzodiazepine use can lead to physical dependence. Suddenly stopping a benzodiazepine can cause rebound anxiety, insomnia, agitation, tremor, and other withdrawal symptoms.
In some cases, abrupt discontinuation can cause serious complications, including seizures.
For this reason, patients should not stop medications such as Xanax, Ativan, Klonopin, or Valium simply because they have read that benzodiazepines might interfere with ketamine.
If a patient and clinician decide that reducing a benzodiazepine makes sense, the clinician should develop an individualized tapering plan and monitor the process appropriately.
A medication review should include more than prescription antidepressants. We want to know about benzodiazepines, stimulants, sleep medications, opioids, anticonvulsants, cannabis, alcohol, supplements, and other substances that could affect safety or treatment response.
We also want to understand why each medication is being used. Someone who takes clonazepam for panic disorder may have different clinical needs from someone who primarily uses a benzodiazepine for sleep.
The goal is not to eliminate medications unnecessarily. Instead, we want to understand the complete pharmacologic picture before designing the treatment plan.
Taking a benzodiazepine does not automatically exclude someone from ketamine therapy. However, the medication, dose, timing, and pattern of use may all matter when a clinician develops a treatment plan.
Most importantly, patients should never abruptly discontinue a benzodiazepine simply to prepare for a ketamine infusion. Any medication change should happen with appropriate medical supervision.
At Seaside Ketamine, we review each patient’s medications and clinical history before treatment. This allows us to consider both safety and the factors that may influence treatment response.
Not necessarily. The appropriate approach depends on your dose, frequency of use, duration of treatment, dependence risk, and overall clinical situation. Your ketamine clinician should review this with you.
Some research has found an association between benzodiazepine use and reduced or delayed antidepressant response to ketamine, but the evidence does not establish that benzodiazepines prevent ketamine from working in every patient.
No. Abrupt discontinuation after regular benzodiazepine use can cause withdrawal and potentially serious complications. Any taper or medication change should be medically supervised.
